GlaxoSmithKline PLC Director/PDMR Shareholding (1492F)

TIDMGSK

RNS Number : 1492F

GlaxoSmithKline PLC

16 February 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated 
        with them ('PCA') 
====  ======================================================================= 
 a)    Name                         Mrs V A Whyte 
====  ============================  ========================================= 
 b)    Position/status              Company Secretary 
====  ============================  ========================================= 
 c)    Initial notification/        Initial Notification 
        amendment 
====  ============================  ========================================= 
 2.    Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
====  ======================================================================= 
 a)    Name                         GlaxoSmithKline plc 
====  ============================  ========================================= 
 b)    LEI                          5493000HZTVUYLO1D793 
====  ============================  ========================================= 
 3.    Details of the transaction(s): section 
        to be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================= 
 a)    Description                   Ordinary shares of 25 pence 
        of the financial              each ('Ordinary Shares') 
        instrument 
                                      ISIN: GB0009252882 
====  ============================  ========================================= 
 b)    Nature of the                A conditional award of Ordinary 
        transaction                  Shares under the Company's 2017 
                                     Performance Share Plan. Vesting 
                                     of the award is subject to meeting 
                                     performance criteria over a 
                                     three-year period. 
====  ============================  ========================================= 
 c)    Price(s) and                   Price(s)              Volume(s) 
        volume(s) 
====  ============================   ====================  ================ 
    GBP12.908                                               11,800 
   ======================================================  ================ 
 
 d)    Aggregated                   n/a (single transaction) 
        information 
==== 
  Aggregated 
   volume Price 
 ===================================================  ======================= 
 e)    Date of the                  2018-02-14 
        transaction 
====  ============================  ========================================= 
 f)    Place of the                 n/a 
        transaction 
====  ============================  ========================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFQLFFVLFFBBV

(END) Dow Jones Newswires

February 16, 2018 06:20 ET (11:20 GMT)